These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11095445)

  • 1. Cerebrospinal fluid corticotropin-releasing hormone in healthy humans: effects of yohimbine and naloxone.
    Vythilingam M; Anderson GM; Owens MJ; Halaszynski TM; Bremner JD; Carpenter LL; Heninger GR; Nemeroff CB; Charney DS
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4138-45. PubMed ID: 11095445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion.
    Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
    J Clin Endocrinol Metab; 1995 Mar; 80(3):802-6. PubMed ID: 7883833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of trauma-related audiovisual stimulation on cerebrospinal fluid norepinephrine and corticotropin-releasing hormone concentrations in post-traumatic stress disorder.
    Geracioti TD; Baker DG; Kasckow JW; Strawn JR; Jeffrey Mulchahey J; Dashevsky BA; Horn PS; Ekhator NN
    Psychoneuroendocrinology; 2008 May; 33(4):416-24. PubMed ID: 18295412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha2-adrenoceptor regulation of the hypothalamic-pituitary-adrenocortical axis in obesity.
    Pasquali R; Vicennati V; Calzoni F; Gnudi U; Gambineri A; Ceroni L; Cortelli P; Menozzi R; Sinisi R; Rio GD
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):413-21. PubMed ID: 10762283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diurnal variation of cerebrospinal fluid immunoreactive corticotropin-releasing hormone levels in healthy volunteers.
    Kling MA; DeBellis MD; O'Rourke DK; Listwak SJ; Geracioti TD; McCutcheon IE; Kalogeras KT; Oldfield EH; Gold PW
    J Clin Endocrinol Metab; 1994 Jul; 79(1):233-9. PubMed ID: 8027234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentrations of corticotropin-releasing hormone, norepinephrine, MHPG, 5-hydroxyindoleacetic acid, and tryptophan in the cerebrospinal fluid of alcoholic patients: serial sampling studies.
    Geracioti TD; Loosen PT; Ebert MH; Ekhator NN; Burns D; Nicholson WE; Orth DN
    Neuroendocrinology; 1994 Dec; 60(6):635-42. PubMed ID: 7535389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Interleukin-1beta stimulates the simultaneous release of norepinephrine in the paraventricular nucleus and the median eminence.
    MohanKumar SM; MohanKumar PS
    Brain Res Bull; 2005 May; 65(5):451-6. PubMed ID: 15833600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders.
    Bao AM; Hestiantoro A; Van Someren EJ; Swaab DF; Zhou JN
    Brain; 2005 Jun; 128(Pt 6):1301-13. PubMed ID: 15705605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans.
    Geracioti TD; Orth DN; Ekhator NN; Blumenkopf B; Loosen PT
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1325-30. PubMed ID: 1317385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The stress system in depression and neurodegeneration: focus on the human hypothalamus.
    Bao AM; Meynen G; Swaab DF
    Brain Res Rev; 2008 Mar; 57(2):531-53. PubMed ID: 17524488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.
    Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    J Clin Endocrinol Metab; 1993 Feb; 76(2):388-91. PubMed ID: 8381800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of naloxone administration on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin in unperturbed horses.
    Alexander SL; Irvine CH
    Endocrinology; 1995 Nov; 136(11):5139-47. PubMed ID: 7588252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated basal adrenocorticotropin and evidence for increased central opioid tone in highly trained male athletes.
    Inder WJ; Hellemans J; Ellis MJ; Evans MJ; Livesey JH; Donald RA
    J Clin Endocrinol Metab; 1995 Jan; 80(1):244-8. PubMed ID: 7829620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia.
    Torpy DJ; Papanicolaou DA; Lotsikas AJ; Wilder RL; Chrousos GP; Pillemer SR
    Arthritis Rheum; 2000 Apr; 43(4):872-80. PubMed ID: 10765933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of alpha(1)- and alpha(2)-adrenoceptors.
    Laorden ML; Fuertes G; González-Cuello A; Milanés MV
    J Pharmacol Exp Ther; 2000 May; 293(2):578-84. PubMed ID: 10773031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central administration of cocaine- and amphetamine-regulated transcript increases phosphorylation of cAMP response element binding protein in corticotropin-releasing hormone-producing neurons but not in prothyrotropin-releasing hormone-producing neurons in the hypothalamic paraventricular nucleus.
    Sarkar S; Wittmann G; Fekete C; Lechan RM
    Brain Res; 2004 Mar; 999(2):181-92. PubMed ID: 14759497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced hypothalamo-pituitary-adrenal axis stress responses in late pregnancy: central opioid inhibition and noradrenergic mechanisms.
    Russell JA; Douglas AJ; Brunton PJ
    Ann N Y Acad Sci; 2008 Dec; 1148():428-38. PubMed ID: 19120138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.